Effect of sunscreen application under maximal-use conditions on plasma concentration of sunscreen active ingredients: a critical appraisal
- PMID: 31834937
- DOI: 10.1111/bjd.18803
Effect of sunscreen application under maximal-use conditions on plasma concentration of sunscreen active ingredients: a critical appraisal
Comment on
-
Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.JAMA. 2019 Jun 4;321(21):2082-2091. doi: 10.1001/jama.2019.5586. JAMA. 2019. PMID: 31058986 Free PMC article. Clinical Trial.
References
-
- Matta MK, Zusterzeel R, Pilli NR et al. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA 2019; 321:2082-91.
-
- US Food and Drug Administration (FDA). Sunscreen drug products for over-the-counter human use: proposed rule. Fed Regist 2019; 84:6204-75.
-
- European Commission. Scientific Committee on Consumer Safety. Opinion on 4-methylbenzylidene camphor. SCCP/1042/06. Available at: https://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_075.pdf (last accessed 11 December 2019).
-
- European Commission. Scientific Committee on Consumer Safety. Opinion on 2-(4-(2-(4-diethylamino-2-hydroxy-benzoyl)-benzoyl)-piperazine-1-carbonyl)-phenyl)-(4-diethylamino-2-hydroxyphenyl)-methanone, HAA299, as UV filter in sunscreen products. SCCS/1533/14. Available at: https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/s... (last accessed 11 December 2019).
-
- Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152:726-32.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
